GO:0006072 glycerol-3-phosphate metabolic process: Lipid Synthesis Hub, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006072 glycerol-3-phosphate metabolic process describes all chemical reactions and pathways involving glycerol-3-phosphate (G3P), a central phosphoric monoester of glycerol.
• G3P sits at the crossroads of glycolysis, lipid biosynthesis, and mitochondrial redox shuttling, making it essential for membrane lipid production and energy metabolism.
• The glycerol-3-phosphate shuttle transfers reducing equivalents from cytosolic NADH into mitochondria and influences ROS signaling, HIF-1alpha stability, and neutrophil function.
• Dysregulated G3P metabolism contributes to senescence, citrin deficiency, chronic kidney disease, and kidney cancer through rewired lipid metabolism and FGF21/FGF23 signaling.
• Key enzymes include cytosolic GPD1 and mitochondrial GPD2, along with glycerol-3-phosphate acyltransferases (GPATs) that commit G3P to glycerophospholipid synthesis.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of G3P metabolic genes in cancer, metabolic disease, and immune cell biology.
Description
Glycerol-3-phosphate (G3P) is a three-carbon phosphoric monoester that serves as a metabolic hub linking carbohydrate breakdown to lipid biosynthesis and mitochondrial redox balance. The Gene Ontology term GO:0006072, glycerol-3-phosphate metabolic process, encompasses the chemical reactions and pathways involving this molecule, including its synthesis from dihydroxyacetone phosphate (DHAP), its oxidation to DHAP, and its incorporation into glycerolipids. Researchers study this process because G3P levels and flux directly influence membrane biogenesis, energy production, and signaling pathways that control cell fate. Recent work has shown that G3P accumulation can trigger cellular senescence by rewiring lipid metabolism, and that G3P activates transcription factors such as ChREBP and FGF21 in metabolic disorders. In immune cells, the glycerol-3-phosphate shuttle supports mitochondrial ROS production and HIF-1alpha stabilization, linking G3P metabolism to inflammatory responses. In kidney cancer, uncoupled G3P shuttle activity reveals that cytosolic GPD is essential for lipid synthesis and tumor growth. These findings position GO:0006072 as a critical process for understanding metabolic adaptation, disease mechanisms, and therapeutic targeting.
glycerol-3-phosphate metabolic process At A Glance
| GO ID | GO:0006072 |
|---|---|
| GO term | glycerol-3-phosphate metabolic process |
| Ontology | biological_process |
| Synonym | glycerol-3-phosphate metabolism |
| Definition | The chemical reactions and pathways involving glycerol-3-phosphate, a phosphoric monoester of glycerol. |
| Major function | Synthesis and utilization of glycerol-3-phosphate for glycerolipid biosynthesis, redox shuttling, and signaling. |
| Key enzymes | GPD1, GPD2, GPATs, GK, and associated phosphatases. |
| Cellular locations | Cytosol, mitochondria, endoplasmic reticulum, and peroxisomes. |
| Related pathways | Glycolysis, glycerophospholipid metabolism, ether lipid metabolism, and oxidative phosphorylation. |
What Is GO:0006072?
GO:0006072 glycerol-3-phosphate metabolic process is defined as the chemical reactions and pathways involving glycerol-3-phosphate, a phosphoric monoester of glycerol. In practical terms, this includes the enzymatic interconversion of glycerol-3-phosphate with dihydroxyacetone phosphate, the acylation of glycerol-3-phosphate to form lysophosphatidic acid, and the transport or shuttling of glycerol-3-phosphate between cellular compartments. The process is central to both lipid biosynthesis and redox metabolism, and it is conserved from bacteria to humans.
Why Is glycerol-3-phosphate metabolic process Important in Cell Biology?
GO:0006072 is important because glycerol-3-phosphate is a metabolic node that connects glucose catabolism to lipid anabolism and mitochondrial redox homeostasis. Perturbations in G3P metabolism have been linked to senescence, metabolic disorders, kidney disease, and cancer, making it a target for both mechanistic studies and therapeutic development. Understanding this process helps researchers interpret how cells balance energy production, membrane synthesis, and signaling under normal and pathological conditions.
• G3P is the backbone for glycerophospholipid and triacylglycerol synthesis, essential for membrane biogenesis and energy storage.
• The glycerol-3-phosphate shuttle transfers cytosolic NADH into mitochondria, affecting ATP production and ROS signaling.
• G3P accumulation triggers senescence by rewiring lipid metabolism, linking this process to aging and age-related diseases.
• In citrin deficiency, G3P activates ChREBP and FGF21, driving lipogenesis and metabolic reprogramming.
• In kidney cancer, cytosolic GPD supports lipid synthesis and tumor growth through an uncoupled G3P shuttle.
• G3P contributes to increased FGF23 production in chronic kidney disease, linking metabolism to phosphate homeostasis.
• Species differences in G3P metabolism reveal trade-offs between metabolic adaptations and cell proliferation.
• Bacterial G3P metabolism in Pseudomonas aeruginosa is critical for its physiology and pathogenesis.
• G3P metabolism is a determinant of neutrophil HIF-1alpha stabilization and inflammatory function.
• Targeting G3P metabolic enzymes offers potential therapeutic strategies in cancer and metabolic disorders.
What Happens During glycerol-3-phosphate metabolic process?
Synthesis of glycerol-3-phosphate from dihydroxyacetone phosphate
In simple terms: The cell makes glycerol-3-phosphate by converting a glycolysis intermediate using NADH.
Cytosolic glycerol-3-phosphate dehydrogenase (GPD1) reduces dihydroxyacetone phosphate (DHAP) to glycerol-3-phosphate using NADH as a cofactor. This reaction is reversible and is a key entry point for G3P into lipid synthesis. In mitochondria, GPD2 catalyzes the same reaction but with different cofactor preferences, contributing to the glycerol-3-phosphate shuttle. The balance between GPD1 and GPD2 activity determines whether G3P is used for lipid production or redox shuttling.
Acylation of glycerol-3-phosphate to lysophosphatidic acid
In simple terms: Glycerol-3-phosphate gets a fatty acid attached to become a lipid building block.
Glycerol-3-phosphate acyltransferases (GPATs) catalyze the first committed step in glycerophospholipid and triacylglycerol synthesis by transferring an acyl group from acyl-CoA to G3P, forming lysophosphatidic acid. This reaction occurs in the endoplasmic reticulum and mitochondria and is rate-limiting for lipid biosynthesis. Different GPAT isoforms have distinct substrate specificities and tissue distributions, influencing lipid composition and storage.
Glycerol-3-phosphate shuttle and redox balance
In simple terms: Glycerol-3-phosphate carries electrons from the cytosol into mitochondria to help make energy.
The glycerol-3-phosphate shuttle consists of cytosolic GPD1 and mitochondrial GPD2, which together transfer reducing equivalents from cytosolic NADH to mitochondrial FAD, ultimately feeding into the electron transport chain. This shuttle is particularly important in tissues with high glycolytic flux and supports mitochondrial ROS production, which can stabilize HIF-1alpha in neutrophils. In kidney cancer, uncoupling of the shuttle reveals that cytosolic GPD is essential for lipid synthesis and tumor growth.
Regulation of glycerol-3-phosphate levels by phosphatases and kinases
In simple terms: Enzymes add or remove phosphate groups to control how much glycerol-3-phosphate is available.
Glycerol-3-phosphate levels are also regulated by glycerol kinase (GK), which phosphorylates glycerol to G3P, and by phosphatases that dephosphorylate G3P to glycerol. In bacteria such as Pseudomonas aeruginosa, G3P metabolism is tightly controlled to balance carbon and energy sources. In mammalian cells, the interplay between synthesis, degradation, and transport determines the size of the G3P pool available for lipid synthesis and signaling.
Glycerol-3-phosphate as a signaling molecule
In simple terms: Glycerol-3-phosphate can also act as a signal to turn on specific genes.
Beyond its metabolic roles, G3P can act as a signaling molecule. In citrin deficiency, G3P activates the transcription factor ChREBP and increases FGF21 transcription, driving lipogenesis. In chronic kidney disease, G3P contributes to increased FGF23 production, linking G3P metabolism to phosphate and vitamin D regulation. These signaling functions highlight the broader impact of GO:0006072 on gene expression and systemic physiology.
Key Genes Involved in GO:0006072 glycerol-3-phosphate metabolic process
The following genes and proteins are central to glycerol-3-phosphate metabolic process and are frequently studied in metabolic, cancer, and immune research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GPD1 | Cytosolic glycerol-3-phosphate dehydrogenase; reduces DHAP to G3P | Essential for lipid synthesis in kidney cancer; target for metabolic studies |
| GPD2 | Mitochondrial glycerol-3-phosphate dehydrogenase; component of G3P shuttle | Influences ROS production and HIF-1alpha stability in neutrophils |
| GPAT1 | Glycerol-3-phosphate acyltransferase 1; catalyzes first step in glycerolipid synthesis | Regulates hepatic lipid metabolism and insulin sensitivity |
| GPAT2 | Glycerol-3-phosphate acyltransferase 2; testis-specific isoform | Potential role in spermatogenesis and lipid metabolism |
| GPAT3 | Glycerol-3-phosphate acyltransferase 3; endoplasmic reticulum isoform | Involved in adipocyte differentiation and lipid storage |
| GPAT4 | Glycerol-3-phosphate acyltransferase 4; ER and lipid droplet associated | Contributes to phospholipid synthesis and membrane homeostasis |
| GK | Glycerol kinase; phosphorylates glycerol to G3P | Links glycerol metabolism to G3P pool; studied in bacteria and mammals |
| GPD1L | Glycerol-3-phosphate dehydrogenase 1-like; regulates G3P levels | Implicated in cancer and cardiac metabolism |
| ChREBP | Transcription factor activated by G3P; regulates lipogenic genes | Mediates G3P-induced lipogenesis in citrin deficiency |
| FGF21 | Hormone induced by G3P via ChREBP; regulates lipid and glucose metabolism | Biomarker and therapeutic target in metabolic disease |
| FGF23 | Phosphate-regulating hormone increased by G3P in CKD | Links G3P metabolism to chronic kidney disease |
| HIF-1alpha | Transcription factor stabilized by mitochondrial ROS from G3P shuttle | Regulates immune cell function and inflammation |
| PPARgamma | Nuclear receptor regulating lipid metabolism; influenced by G3P flux | Target for metabolic syndrome and diabetes research |
| SREBP1 | Transcription factor controlling lipogenic gene expression | Downstream of G3P-mediated lipogenesis |
| ACSL1 | Acyl-CoA synthetase providing acyl-CoA for GPAT reactions | Supports G3P acylation in lipid synthesis |
| DGAT1 | Diacylglycerol acyltransferase; converts DAG to TAG using G3P-derived intermediates | Final step in triacylglycerol synthesis |
| DGAT2 | Diacylglycerol acyltransferase 2; ER isoform | Contributes to lipid droplet formation |
| AGPAT | 1-acylglycerol-3-phosphate acyltransferase; converts LPA to PA | Second step in glycerophospholipid synthesis |
How Is glycerol-3-phosphate metabolic process Regulated?
Glycerol-3-phosphate metabolic process is regulated at multiple levels. Transcriptional control of GPD1 and GPD2 responds to nutrient status and hypoxia, influencing G3P flux. The ChREBP transcription factor is activated by G3P itself, creating a feed-forward loop that enhances lipogenic gene expression. In chronic kidney disease, G3P contributes to increased FGF23 production, which in turn regulates phosphate homeostasis. Post-translational modifications and allosteric regulation of GPATs and GPDs further modulate enzyme activity. Additionally, species-specific differences in G3P metabolism reveal trade-offs between metabolic adaptations and cell proliferation, suggesting evolutionary pressures shape this pathway.
glycerol-3-phosphate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPD1 | Kidney cancer; lipid synthesis dependency | GPD1 knockout in renal cancer cell lines; xenograft models |
| GPD2 | Neutrophil inflammation; HIF-1alpha stabilization | GPD2 knockout in neutrophils; ROS and HIF-1alpha assays |
| ChREBP | Citrin deficiency; lipogenesis and FGF21 activation | ChREBP knockout in hepatocytes; G3P treatment |
| FGF23 | Chronic kidney disease; phosphate homeostasis | FGF23 reporter cells; G3P stimulation |
| GPATs | Metabolic syndrome; hepatic steatosis | GPAT isoform knockout mice; lipid profiling |
Glycerol-3-phosphate metabolism in cancer
In kidney cancer, the glycerol-3-phosphate shuttle is uncoupled, and cytosolic GPD (GPD1) is essential to support lipid synthesis and tumor growth. This dependency highlights G3P metabolism as a potential therapeutic target in cancers with high lipogenic demand. Additionally, G3P accumulation can trigger senescence by rewiring lipid metabolism, which may influence tumor suppression or aging.
Glycerol-3-phosphate metabolism in metabolic and kidney diseases
In citrin deficiency, elevated G3P activates ChREBP and FGF21 transcription, driving lipogenesis and contributing to metabolic dysfunction. In chronic kidney disease, G3P contributes to increased FGF23 production, linking G3P metabolism to phosphate and vitamin D dysregulation. These findings suggest that targeting G3P metabolic enzymes could ameliorate aspects of these disorders.
Glycerol-3-phosphate metabolism in immune and inflammatory responses
Neutrophil HIF-1alpha stabilization is augmented by mitochondrial ROS produced via the glycerol-3-phosphate shuttle, linking G3P metabolism to immune cell function and inflammation. This connection suggests that G3P metabolic flux can modulate innate immune responses and may be relevant in inflammatory diseases.
Glycerol-3-phosphate metabolism in aging and senescence
A homoeostatic switch causing glycerol-3-phosphate and phosphoethanolamine accumulation triggers senescence by rewiring lipid metabolism. This identifies G3P as a metabolite that can drive cellular aging, with implications for age-related diseases and regenerative medicine.
From glycerol-3-phosphate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GPD1 loss impair tumor growth in kidney cancer? | GPD1 knockout in renal cancer cell lines and mouse xenografts |
| Does GPD2 deficiency affect neutrophil HIF-1alpha stabilization? | GPD2 knockout in neutrophil-like cells; ROS and HIF-1alpha Western blot |
| Does G3P activate ChREBP and FGF21 transcription? | ChREBP knockout hepatocytes treated with G3P; luciferase reporter assays |
| Does G3P contribute to FGF23 production in CKD? | FGF23 promoter reporter in kidney cells; G3P stimulation |
| What is the role of GPAT isoforms in lipid synthesis? | GPAT knockout cell lines; lipidomics and acyltransferase assays |
| How does G3P accumulation trigger senescence? | Inducible G3P accumulation models; senescence markers and lipidomics |
How to Study the glycerol-3-phosphate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Glycerol-3-phosphate and related metabolite levels | Quantifying G3P pool size in cells and tissues |
| Lipidomics | Glycerophospholipid and triacylglycerol species | Assessing lipid synthesis downstream of G3P |
| GPD activity assay | NADH oxidation/reduction rate | Measuring GPD1/GPD2 enzymatic activity |
| GPAT activity assay | Acyltransferase activity using radiolabeled acyl-CoA | Determining GPAT isoform function |
| RNA-seq | Transcriptome changes | Identifying G3P-responsive genes and pathways |
| Western blot | Protein expression and phosphorylation | Detecting HIF-1alpha stabilization and signaling |
| CRISPR knockout screening | Gene essentiality and metabolic fitness | Discovering regulators of G3P metabolism |
| Senescence assays | Beta-galactosidase activity, proliferation arrest | Linking G3P accumulation to senescence |
Metabolomics and lipidomics
Mass spectrometry-based metabolomics and lipidomics are essential to quantify glycerol-3-phosphate levels and downstream lipid species. These methods can reveal how genetic perturbations in GPD1, GPD2, or GPATs alter G3P flux and lipid composition.
Enzyme activity assays
Colorimetric or fluorometric assays measure glycerol-3-phosphate dehydrogenase and acyltransferase activities in cell lysates or purified fractions. These assays help determine kinetic parameters and the impact of mutations on enzyme function.
Gene expression analysis
RNA-seq and qPCR are used to assess transcriptional changes in G3P metabolic genes and downstream targets such as FGF21 and ChREBP. Reporter assays can further dissect promoter regulation by G3P-responsive transcription factors.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes that modulate G3P metabolism and sensitivity to metabolic stress. Such screens are valuable for uncovering novel regulators and therapeutic targets.
How CRISPR Can Be Used to Study GO:0006072 glycerol-3-phosphate metabolic process
Knockout
CRISPR knockout of GPD1, GPD2, or GPATs allows researchers to determine their essential roles in glycerol-3-phosphate metabolism, lipid synthesis, and cell proliferation. For example, GPD1 knockout in kidney cancer cells reduces lipid synthesis and impairs tumor growth.
Point Mutation
Introducing point mutations in catalytic residues of GPD1 or GPATs can dissect enzymatic mechanisms and separate metabolic from signaling functions. Such models are valuable for understanding how specific amino acids contribute to substrate binding and catalysis.
Knock-in
Knock-in of tagged versions of GPD1, GPD2, or GPATs enables live-cell imaging and proteomic analysis of protein localization and interactions. This approach can reveal dynamic changes in G3P metabolic enzymes under different conditions.
Overexpression
Overexpression of GPD1 or GPATs can increase G3P flux and lipid accumulation, modeling conditions of metabolic overload. This is useful for studying G3P-induced signaling, such as ChREBP activation and FGF21 induction.
How EDITGENE Supports glycerol-3-phosphate metabolic process Research
Researchers studying glycerol-3-phosphate metabolic process-related genes often need to determine whether a candidate gene is causally involved in lipid synthesis, redox balance, or disease progression. EDITGENE provides comprehensive CRISPR services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for glycerol-3-phosphate metabolic process research.
Frequently Asked Questions About glycerol-3-phosphate metabolic process
What is glycerol-3-phosphate metabolic process?
It is the set of chemical reactions and pathways involving glycerol-3-phosphate, a central metabolite in lipid synthesis and energy metabolism, defined by GO:0006072.
What genes are involved in glycerol-3-phosphate metabolic process?
Key genes include GPD1, GPD2, GPAT1-4, GK, and transcription factors like ChREBP that respond to G3P levels.
How is glycerol-3-phosphate produced?
Glycerol-3-phosphate is produced by reduction of dihydroxyacetone phosphate by GPD1 or GPD2, or by phosphorylation of glycerol by glycerol kinase.
What is the glycerol-3-phosphate shuttle?
It is a mitochondrial redox shuttle that transfers electrons from cytosolic NADH to the electron transport chain via GPD1 and GPD2, influencing ROS and HIF-1alpha.
How does glycerol-3-phosphate affect cancer?
In kidney cancer, cytosolic GPD supports lipid synthesis and tumor growth, making G3P metabolism a potential therapeutic target.
What diseases are linked to glycerol-3-phosphate metabolism?
Senescence, citrin deficiency, chronic kidney disease, and kidney cancer have been linked to altered G3P metabolism.
How can I study glycerol-3-phosphate metabolism in the lab?
Common methods include metabolomics, lipidomics, enzyme activity assays, RNA-seq, and CRISPR knockout screens.
What is the role of GPAT in glycerol-3-phosphate metabolism?
GPAT enzymes acylate glycerol-3-phosphate to form lysophosphatidic acid, the first committed step in glycerolipid synthesis.
Does glycerol-3-phosphate act as a signaling molecule?
Yes, G3P can activate ChREBP and increase FGF21 transcription in citrin deficiency, and contribute to FGF23 production in CKD.
How does EDITGENE support glycerol-3-phosphate research?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for G3P metabolic genes.
Conclusion
GO:0006072 glycerol-3-phosphate metabolic process is a fundamental biological process that connects carbohydrate metabolism to lipid biosynthesis, redox balance, and signaling. Its dysregulation is implicated in cancer, metabolic disorders, kidney disease, and aging, making it a rich area for mechanistic and therapeutic research. By leveraging CRISPR-based models and multi-omics approaches, researchers can dissect the causal roles of G3P metabolic genes and identify new targets for intervention.
References
- 1. Tighanimine K et al.. 2024. A homoeostatic switch causing glycerol-3-phosphate and phosphoethanolamine accumulation triggers senescence by rewiring lipid metabolism.. Nat Metab 6(2):323-342 PMID: 38409325
- 2. Tiwari V et al.. 2025. Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency.. Nat Metab 7(11):2284-2299 PMID: 41238906
- 3. Liu Y et al.. 2022. Metabolic Mechanism and Physiological Role of Glycerol 3-Phosphate in Pseudomonas aeruginosa PAO1.. mBio 13(6):e0262422 PMID: 36218368
- 4. Willson JA et al.. 2022. Neutrophil HIF-1α stabilization is augmented by mitochondrial ROS produced via the glycerol 3-phosphate shuttle.. Blood 139(2):281-286 PMID: 34411229
- 5. Yao CH et al.. 2023. Uncoupled glycerol-3-phosphate shuttle in kidney cancer reveals that cytosolic GPD is essential to support lipid synthesis.. Mol Cell 83(8):1340-1349.e7 PMID: 37084714
- 6. Chen X et al.. 2011. sn-Glycerol-3-phosphate acyltransferases in plants.. Plant Signal Behav 6(11):1695-9 PMID: 22057337
- 7. Gaertner K et al.. 2025. Species differences in glycerol-3-phosphate metabolism reveals trade-offs between metabolic adaptations and cell proliferation.. Biochim Biophys Acta Bioenerg 1866(2):149530 PMID: 39631556
- 8. Simic P et al.. 2025. Glycerol-3-phosphate contributes to the increase in FGF23 production in chronic kidney disease.. Am J Physiol Renal Physiol 328(2):F165-F172 PMID: 39716914
